Telomir Pharmaceuticals, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
Telomir Pharmaceuticals, Inc. (TELO) reported Adjustments to Additional Paid in Capital, Warrant Issued of $5.95 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-02-04.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2025-02-04
- Telomir Pharmaceuticals, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-12-31 was $0.00.
- Telomir Pharmaceuticals, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-09-30 was $0.00.
- Telomir Pharmaceuticals, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-06-30 was $5.95M.
- Telomir Pharmaceuticals, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2023 was $5.95M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-04 | $0.00 derived: sum of 2 quarters · filed 2025-02-04 | $5.95M derived: sum of 3 quarters · filed 2025-02-04 | $5.95M 10-K · filed 2025-02-04 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $5.95M derived: sum of 2 quarters · filed 2024-11-12 | $5.95M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $5.95M 10-Q · filed 2024-08-13 | $5.95M 10-Q · filed 2024-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |